The Future of Precision Medicine Starts at the Moment of Diagnosis OCTOBER 28, 2025 | 11:30AM ET | VIRTUAL EVENT Join Access25 on October 28 to discover how Proscia is removing one of the biggest barriers to realizing precision...

Agilent: Providing a comprehensive digital diagnostic pathology system for enhanced clinical utility SANTA CLARA, Calif., March 08, 2023 Agilent Technologies Inc. (NYSE: A) today announced a multi-year distribution agreement with...

Akoya Collaborating with Agilent to Catalyze Precision Medicine We recently announced a partnership with Agilent to develop multiplex diagnostic solutions for tissue analysis and to commercialize workflow solutions for these...

Agilent and Akoya Biosciences: Will commercialize end-to-end workflow solutions for tissue biomarker analysis in companion diagnostic development SANTA CLARA, Calif, & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Agilent Technologies,...

Agilent Technologies Inc. (NYSE: A), a leader in life sciences, diagnostics, and applied chemical markets, and Visiopharm, a leader in AI-based digital pathology, today announced the signing of a worldwide distribution agreement, enabling...

We hope to see you during the joint Visiopharm & Agilent presentation at DigiBase’s complimentary Transforming Digital Pathology webinar! Accelerating Accurate Diagnosis APRIL 30, 2021 | 6:25AM-7:15am (EST) | 11:25AM-12:15PM (BST) |...